WO2015140251A1 - Drainage tube for urine in silicone with carbon coating for supporting an absorbable device for tissue reconstruction of urethral segment - Google Patents
Drainage tube for urine in silicone with carbon coating for supporting an absorbable device for tissue reconstruction of urethral segment Download PDFInfo
- Publication number
- WO2015140251A1 WO2015140251A1 PCT/EP2015/055785 EP2015055785W WO2015140251A1 WO 2015140251 A1 WO2015140251 A1 WO 2015140251A1 EP 2015055785 W EP2015055785 W EP 2015055785W WO 2015140251 A1 WO2015140251 A1 WO 2015140251A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patch
- implant
- drainage tube
- urethra
- silicone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/303—Carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/047—Urethrae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
Definitions
- the present invention relates to a drainage tube for urine used in combination with at least one absorbable tubular patch for the replacement of a natural segment of urethra in the tissue reconstruction of natural segments of urethra following surgical removal.
- the present invention relates to the use of said drainage tube for avoiding urine leaking from the pre-sphincter section of urethra during the tissue reconstruction of natural segments which have been removed.
- the urethra may require surgical "repair" when affected by some disorders such as for example stenosis, tumours, necrosis, injury, iatrogenic lesions and the like, or by congenital malformations.
- This surgical repair consists in the removal of a damaged section of urethra and in its replacement with flaps of autologous tissue taken from the patient so as to reconstruct naturally the tissue part removed.
- flaps generally come from the intestine, from the buccal mucosa and also from the peritoneal tissue.
- WO02/04039 A2 describes a system for the reconstruction of the urethra formed by a porous external patch and by an internal tube in silicone distanced from said patch where a third component is provided, in the form of a flexible tube placed between the external patch and the internal drainage tube, in order to apply autologous cells cultivated in vitro which migrate towards the outer surface of the patch, populating it.
- WO2011/082295 A2 describes a coated graft which is housed in the patient permanently in that it constitutes the tube for bypassing occluded arteries, where the external coating of the graft in silicone has communication channels which traverse the thickness of the graft.
- FR2759575 Al describes an artificial endoprosthesis for bladder where a urine discharge sphincter is provided formed by a single small tube made up of two layers, one different from the other.
- WO2010/078949 Al describes an artificial endoprosthesis where the natural urethra is connected to the endoprosthesis by suturing the end of the urethra to said endoprosthesis without providing for the replacement of any segment of urethra with artificial tubular devices.
- ⁇ 20121555 A describes an artificial endoprosthesis where the natural urethra is connected to the endoprosthesis by forcedly inserting it inside a hollow truncated cone element placed in the lower portion of said endoprosthesis, without providing for the replacement of any segment of urethra with artificial tubular devices.
- the object of the present invention is that of overcoming, at least in part, the disadvantages of the prior art by providing an implant for the replacement and reconstruction of at least one segment of urethra which has been removed, which is improved with respect to the occurance of post-surgical bacterial infections and which avoids the leakage of said urine towards the surrounding tissues.
- a further object is that of providing such an implant which is easy and simple to make, and also economical.
- Yet another object is that of providing such an implant which has moreover substantially the same elastic and urine impermeability properties typical of the natural urethra and which allows the dimensions of the natural lumen of the urethra to be maintained constant even under the weight of the regrowing tissue segment.
- One object of the present invention relates to a flexible and biocompatible drainage tube, with homogeneous and continuous surface, made in silicone coated with pyrolytic turbostratic carbon, for the use in association with a tubular patch for urethra, of the type not coated externally, made in resorbable or non-resorbable material and in the form of a polymeric membrane or fibres fabric, wherein said patch is intended to replace at least one natural segment of urethra removed previously.
- Said drainage tube which has a slightly smaller outer diameter compared to the inner diameter of the urethra, is placed partly along the entire pre-sphincter section of urethra and partly inside the bladder (natural or artificial) and attached to said urethra with absorbable suture stitches.
- This drainage tube has an inner diameter that varies from 12-14 French (Fr) or Charrier (Ch) up to a max of 24 Fr (or Ch) and a length that varies from 5 to 20 cm.
- Said drainage tube for urine in silicone with carbon coating also acts as inner support for an absorbable device (patch) for tissue reconstruction of urethral segment.
- This tube is made by extrusion, moulding or thermoforming of a silicone polymer suitable for medical use which is subsequently coated completely with a microfilm of pyrolytic turbostratic carbon, generally with thickness equal to approximately 0.2-0.3 microns on both inner and outer surfaces.
- the silicone used for said drainage tube can consist, for example, of copolymers of dimethyl- and methavynil-siloxane reinforced with silicon.
- a medical silicone is preferably used, such as for example the one known by the code MED 4735TM and marketed by the company Nusil Technology. This silicone shows properties, such as tensile strength and elongation, particularly suitable for the application in the construction of a flexible tubular device.
- said layer of pyrolytic turbostratic carbon takes place according to the prior art for the obtaining of ultra-thin films in the order of the microns indicated above, for example using a PVD (physical vapour deposition) method.
- Said coating in pyrolytic turbostratic carbon is found to be neutral when in contact with biological molecules, for example the cells of growing new tissues.
- the surfaces of the present drainage tube coated with pyrolytic turbostratic carbon are resistant to urine and remain free from incrustation and smooth over time.
- Said drainage tube is flexible and not expandable radially with such a radial rigidity as to be able to support both a tubular patch and the autologous tissue growing on said patch, thus also acting as scaffold.
- said drainage tube is capable of withstanding the radial stresses of the new tissue growing on the tubular patch so as to avoid reductions, both substantial and minimal, of the lumen of the tissue segment regrowing.
- said drainage tube is inserted through the opening created and placed along the entire pre-sphincter urethra section and partly in the bladder. Subsequently said tube is fixed in position by means of sutures at the entry of the urethra in the bladder.
- said drainage tube is coupled to a tubular patch as defined above, which can optionally be constructed during the operation with the winding of a planar patch around the tube and the tubular construction in situ of the patch for urethra in a similar manner to what takes place in the prior art already described by the Applicant.
- the tubular patch and the drainage tube are completely in contact one with the other without leaving any free space between them.
- the combined use of the present drainage tube with the features defined above with the tubular patch results in an implant for the replacement of one or more removed urethral segments which is improved since it allows not only the complete drainage of the urine from the bladder without side leaks but also the support of the urethral tissue growing on said patch thanks to the properties of radial rigidity provided by the drainage tube.
- said implant is found to be extremely reliable in that the aforesaid drainage tube in coated silicone is extremely resistant to urine and incrustations are not deposited on its surfaces.
- “Patch” here is intended to denote soft substrates, in a flat sheet or plate or tubular shape, used in medicine to repair soft tissues, provided with a greater flexibility and elasticity with respect to the scaffolds and to the substrates known as "mesh”, “mesh tape” or reinforcement nets.
- the present patch is of the type not coated externally since it is implanted in the patient without any coating, in particular without any coating of cultured cells, both internally and externally.
- Said patch is preferably constructed in tubular form during the operating session starting from a planar patch, in the form of a polymeric membrane or sheet or in the form of fibres fabric, which is wound externally around the drainage tube, without leaving space between the two, stitched longitudinally and then attached to the ends of the resected section of urethra as will be explained here below. It is also to be understood that a patch can also be used in a single tubular piece, already ready for use, made by means of moulding or extrusion of an appropriate polymeric material, without thereby departing from the scope of the present invention.
- the thickness of the patch can vary from 0.1 microns to 80 microns, preferably around 20-30 microns.
- Said patch is made with a biocompatible material which can be resorbable or non- resorbable, preferably PGA so as not to determine any type of alteration in the tissues with which it comes into contact.
- PGA is a resorbable thermoplastic polymer characterised by a high degree of crystallinity, around 45-55% in the case of the homopolymer. Despite the fact this material degrades thanks to processes of random hydrolysis, and also thanks to some classes of enzymes, such as those belonging to the family of the esterases, it is particularly suitable for not deteriorating in contact with urine for a period of at least two months, not showing any swelling (increase in volume and dimensions) during this period.
- PGA also has a time of degradation which ranges from 4-6 months even arriving at 12 months, yet starts to lose its mechanical strength already after 4 weeks and it is completely lost at the fifth month. This is compatible with the cell growth of the tissues of the urethra.
- the patch is in PGA, it is preferably in the form of PGA fabric, optionally textured.
- the PGA fabric is made using an ultra-lightweight multifilament or monofilament yarn deriving from PGA fibres.
- the PGA fabric of the patch used in the present invention can be made by weaving in various ways said PGA monofilament or multifilament, creating a knit fabric, a woven fabric or a nonwoven fabric.
- a knit fabric in particular warp knit, in that provided with a rougher surface with respect to the other types mentioned above.
- the fabric of the patch in PGA is textured. It has in fact been found that texturing, as well as making the fabric rougher on the surface, also confers a greater impermeability to urine with respect to a non-textured fabric. In fact it can be presumed that the texturing goes to cover further the micro holes which exist between the meshes of the fabric. Texturing of the fabric can be carried out in various ways: through the use of rough surface monofilament obtained according to the methods known in the art, or by heat setting treatment of the fabric to obtain raised parts in the fibres, adding greater volume to the filament. This latter method of texturing is preferred. It is also possible to make the patch (in planar or tubular form) with biocompatible polymers other than PGA, such as for example polylactic acid (PLA), polycaprolactone (PCL) or mixtures thereof.
- PLA polylactic acid
- PCL polycaprolactone
- polymers which can be used as patch and normally used in the medical field can be silicone, polysulfone, PE, PP, Dacron (PET), PTFE, PVC, polypropylene and polystyrene, Nylon (66 or 6), Kevlar and more generally synthetic polyamides, Mylar, PE, polyurethanes (Biomer, Pellethane, Corethane and Tecoflex) and polyureas, polyacrylates and others, preferably completely covered by a layer of pyrolytic turbostratic carbon, with a thickness generally around 0.2-0.3 microns, to improve biocompatibility.
- PGA programmable gate array
- a flexible and elastic membrane in soft silicone which is coated completely with pyrolytic turbostratic carbon with thickness of approximately 0.2-0.3 microns on both sides of the membrane.
- the starting point is a planar patch which is then wound externally around the tube for drainage inserted between the two free ends of the urethra and stitched longitudinally with suture yarn (resorbable or non- resorbable according to the type of material of the patch) so as to form a tubular patch.
- suture yarn resorbable or non- resorbable according to the type of material of the patch
- the tubular patch in a single piece or the membrane of the planar patch from which the non-resorbable tubular device is to be obtained in situ can also incorporate in its thickness a reinforcement net in Dacron which can facilitate the suture of the patch to the urethra avoiding the tearing of said sutures, and/or provide a greater rigidity according to the need.
- Fig. 1 is a perspective and partial view of the pre-sphincter urethra section from which a necrotic segment has been removed, intended to be replaced during the operation by the patch illustrated in a blown-up view;
- Figure 2 is a partially sectioned overall view of a human urinary system including bladder and pre-sphincter urethra with the necrotic section removed;
- Fig. 3 illustrates the planar patch of Fig. 1 wound around the tube for drainage of Fig. 2 to form during the operation the tubular device in the removed section of urethra.
- Figure 2 illustrates the pre-sphincter section of a urethra, denoted by reference numeral 1, affected by necrosis with the necrotic portion removed.
- urethra has been affected by pathologies other than necrosis such as stenosis, tumours, trauma, iatrogenic lesions and the like, or by congenital malformations.
- This tubular patch denoted in Figure 3 by reference numeral 100, is normally made during the operation by the surgeon starting from a planar patch 3, illustrated in Figure 1.
- a drainage tube 10 (Fig. 2) is inserted inside respective lumens 7, 7' (Fig. 2) at the free ends of the two detached segments 2, 2' of urethra.
- Said tube for drainage 10 can be straight or slightly curved at the tip if it is necessary to facilitate its passage through the curving of the prostatic urethra.
- said tube 10 can extend just slightly beyond the entrance 4 of the urethra into the bladder or extend as far as the centre of the bladder (Fig. 2) without thereby departing from the scope of the present invention.
- the tube 10 After having inserted the tube for drainage 10 in the lumens 7, 7' of the free ends 2, 2' of the two urethra segments, the tube 10 is sutured along the perimeter of the entrance 4 of the urethra in the bladder 8, using sutures 9 made with yarn for sutures with diameter 1/2 in resorbable material, for example Vycril.
- the patch in planar form 3 is wound around the portion of drainage tube 10 which is visible, then stitching longitudinally said patch 3 so as to create the tubular patch 100.
- the longitudinal stitching (not illustrated in the drawing) will be carried out with resorbable or non-resorbable suture yarn according to the type of material used for the patch.
- said patch 3 and said suture yarn for patch are made in resorbable material.
- tubular patch 100 Once the tubular patch 100 has formed around the tube for drainage 10 its ends are sutured to the free ends of the segments 2, 2' of urethra by means of head-to-head sutures 11 (i.e. the two terminal portions of the lumen of the ureter and of the tubular device are facing one to the other and sutured with continuity).
- head-to-head sutures 11 i.e. the two terminal portions of the lumen of the ureter and of the tubular device are facing one to the other and sutured with continuity).
- the tube for drainage 10 will be held in the pre- sphincter urethra section until total regrowth of the urethral new tissue on the patch, generally for a period of approximately 2 months. After which the drainage tube 10 may be removed without surgical intervention, through simple withdrawal thanks to the resorbability of the stitches used.
- the ends of the tubular patch 100 will be fitted over the corresponding free ends of the urothelial tubular tissues 6 and 6' and subsequently the flaps of the incision will be brought close together and sutured longitudinally with resorbable yarn so as to restore the external tubular sheath 5 and 5', then suturing as a sandwich the perimeter edge of the tubular patch 100 to both said tissues by means of sutures along the circumference.
- tubular patch 3 is supported with a specific tubular mesh support, of length substantially equal to that of the patch, as described in the patent application MI2013A001716 incorporated here in full for reference, and in this case the drainage tube 10 will be placed inside said tubular support around which said tubular patch 3 is placed. In this case too, once inserted one inside the other, the tubular patch, the tubular support and the drainage tube will be completely in contact one with the other without leaving any free space between the three elements (drainage tube, tubular support, tubular patch).
- the polymer of the support is preferably resorbable, for example PGA/PLA (poly(lactic- co-glycolic) acid) the copolymer of lactic acid and glycolic acid
- PLA poly(lactic- co-glycolic) acid
- PLA poly(lactic- co-glycolic) acid
- PLA poly(lactic- co-glycolic) acid
- PLA poly(lactic- co-glycolic) acid
- PLA poly(lactic- co-glycolic) acid
- PLA poly(lactic- co-glycolic) acid
- PLA poly(lactic- co-glycolic) acid
- PLA poly(lactic- co-glycolic) acid
- the PLLA poly(L- lactic)acid
- the PLLA has a crystallinity of 37%, a glass transition temperature between 50 and 80°C and a melting temperature of 173-178°C, while the polymer deriving from the polymerisation of a racemic mixture of D and L isomers, the PDLLA, is amorphous.
- PLA polymeric blend of the two single PLA polymers as defined above and PGA.
- PLLA is used as PLA.
- the copolymer PLLA/PGA (or blend of PGA and PLLA) is formed by 30% of PGA and by 70% of PLLA; preferably as PLLA/PGA a poly(L-lactic-co-glycolic) (PLLA/PGA) copolymer is used in which the L-lactic acid is 82-88% in moles while the glycolic acid is 18-12% in moles.
- PLLA/PGA poly(L-lactic-co-glycolic) copolymer
- This specific material makes it possible to obtain a support with mechanical properties of rigidity necessary for supporting the weight of the tubular patch on which the autologous tissue of the urethra is regrowing.
- Said support can be obtained by means of moulding, for example injection moulding, and/or thermoforming of the PGA/PLA.
- moulding for example injection moulding, and/or thermoforming of the PGA/PLA.
- thermoforming of the PGA/PLA.
- the diameter of the support for the tubular patch can be approximately 10 mm in the case of adults and approximately 6 mm in the case of paediatric applications, with a length of 7 mm.
- the thickness of the support is generally comprised between 0.056 mm to 1.15 mm or in any case extremely reduced in order to offer the minimal resistance to the urinary flow.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Composite Materials (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
A description is given of an implant (100) for use in the replacement of at least one urethral segment removed, comprising a tubular resorbable patch (100) for connecting two separated segments (2,2') of urethra having a respective lumen (7, 7'), said tubular patch (100) being formed in a tubular shape during the surgical session from a planar patch (3), characterised in that it also comprises, inside said patch (100), a flexible tube for urine drainage (10) in silicone coated with a microfilm of pyrolytic turbostratic carbon, said tube (10) being apt to be arranged along the entire pre-sphincter section (1) of said urethra without said urethral segment and in part inside the corresponding bladder, and attached to said bladder by means of resorbable sutures (9).
Description
DRAINAGE TUBE FOR URINE IN SILICONE WITH CARBON COATING FOR SUPPORTING AN ABSORBABLE DEVICE FOR TISSUE RECONSTRUCTION OF URETHRAL SEGMENT DESCRIPTION
The present invention relates to a drainage tube for urine used in combination with at least one absorbable tubular patch for the replacement of a natural segment of urethra in the tissue reconstruction of natural segments of urethra following surgical removal.
More particularly the present invention relates to the use of said drainage tube for avoiding urine leaking from the pre-sphincter section of urethra during the tissue reconstruction of natural segments which have been removed. The urethra may require surgical "repair" when affected by some disorders such as for example stenosis, tumours, necrosis, injury, iatrogenic lesions and the like, or by congenital malformations.
This surgical repair consists in the removal of a damaged section of urethra and in its replacement with flaps of autologous tissue taken from the patient so as to reconstruct naturally the tissue part removed.
These flaps generally come from the intestine, from the buccal mucosa and also from the peritoneal tissue.
Autologous tissues, while ensuring the nonexistence of rejection by the patient, do not however have the same elastic features typical of the urethra nor its impermeability to urine in that they are not tissues with urothelial cells. In order to overcome these disadvantages the Applicant has proposed the use, as permanent implant in place of a removed segment of urethra, of an elastic and flexible tubular device, made with a textured PGA fabric, as provided for example in the application MI2013A00080, or made with a supported tubular patch, as provided for example in the application MI2013A001716.
However said permanent implant has some disadvantages. In the first place, since urine
represents a favourable terrain for the growth of most micro-organisms, the leaks of urine which take place near the removed zone exiting from the pre- sphincter urethral duct can spread the infection to other surrounding tissues. Moreover these leaks cannot be held back since the surrounding tissues do not contain urothelial cells impermeable to urine.
WO02/04039 A2 describes a system for the reconstruction of the urethra formed by a porous external patch and by an internal tube in silicone distanced from said patch where a third component is provided, in the form of a flexible tube placed between the external patch and the internal drainage tube, in order to apply autologous cells cultivated in vitro which migrate towards the outer surface of the patch, populating it.
WO2011/082295 A2 describes a coated graft which is housed in the patient permanently in that it constitutes the tube for bypassing occluded arteries, where the external coating of the graft in silicone has communication channels which traverse the thickness of the graft.
FR2759575 Al describes an artificial endoprosthesis for bladder where a urine discharge sphincter is provided formed by a single small tube made up of two layers, one different from the other.
WO2010/078949 Al describes an artificial endoprosthesis where the natural urethra is connected to the endoprosthesis by suturing the end of the urethra to said endoprosthesis without providing for the replacement of any segment of urethra with artificial tubular devices.
ΓΓΜΙ20121555 A describes an artificial endoprosthesis where the natural urethra is connected to the endoprosthesis by forcedly inserting it inside a hollow truncated cone element placed in the lower portion of said endoprosthesis, without providing for the replacement of any segment of urethra with artificial tubular devices.
The object of the present invention is that of overcoming, at least in part, the disadvantages of the prior art by providing an implant for the replacement and reconstruction of at least one segment of urethra which has been removed, which is improved with respect to the occurance of post-surgical bacterial infections and which avoids the leakage of said urine towards the surrounding tissues.
A further object is that of providing such an implant which is easy and simple to make, and also economical. Yet another object is that of providing such an implant which has moreover substantially the same elastic and urine impermeability properties typical of the natural urethra and which allows the dimensions of the natural lumen of the urethra to be maintained constant even under the weight of the regrowing tissue segment. These and other objects are achieved by the implant for the tissue reconstruction of natural segments of urethra following surgical removal comprising a drainage tube for urine in accordance with the invention having the features listed in the annexed independent claim 1. Advantageous embodiments of the invention are disclosed by the dependent claims.
One object of the present invention relates to a flexible and biocompatible drainage tube, with homogeneous and continuous surface, made in silicone coated with pyrolytic turbostratic carbon, for the use in association with a tubular patch for urethra, of the type not coated externally, made in resorbable or non-resorbable material and in the form of a polymeric membrane or fibres fabric, wherein said patch is intended to replace at least one natural segment of urethra removed previously.
Said drainage tube, which has a slightly smaller outer diameter compared to the inner diameter of the urethra, is placed partly along the entire pre-sphincter section of urethra and partly inside the bladder (natural or artificial) and attached to said urethra with absorbable suture stitches.
This drainage tube has an inner diameter that varies from 12-14 French (Fr) or Charrier (Ch) up to a max of 24 Fr (or Ch) and a length that varies from 5 to 20 cm.
Said drainage tube for urine in silicone with carbon coating also acts as inner support for an absorbable device (patch) for tissue reconstruction of urethral segment.
This tube is made by extrusion, moulding or thermoforming of a silicone polymer suitable for medical use which is subsequently coated completely with a microfilm of pyrolytic
turbostratic carbon, generally with thickness equal to approximately 0.2-0.3 microns on both inner and outer surfaces.
The silicone used for said drainage tube can consist, for example, of copolymers of dimethyl- and methavynil-siloxane reinforced with silicon. A medical silicone is preferably used, such as for example the one known by the code MED 4735™ and marketed by the company Nusil Technology. This silicone shows properties, such as tensile strength and elongation, particularly suitable for the application in the construction of a flexible tubular device.
The application of said layer of pyrolytic turbostratic carbon takes place according to the prior art for the obtaining of ultra-thin films in the order of the microns indicated above, for example using a PVD (physical vapour deposition) method. Said coating in pyrolytic turbostratic carbon is found to be neutral when in contact with biological molecules, for example the cells of growing new tissues.
Moreover the surfaces of the present drainage tube coated with pyrolytic turbostratic carbon are resistant to urine and remain free from incrustation and smooth over time.
Said drainage tube is flexible and not expandable radially with such a radial rigidity as to be able to support both a tubular patch and the autologous tissue growing on said patch, thus also acting as scaffold. In practice said drainage tube is capable of withstanding the radial stresses of the new tissue growing on the tubular patch so as to avoid reductions, both substantial and minimal, of the lumen of the tissue segment regrowing.
After having removed the necrotic section of the urethra, said drainage tube is inserted through the opening created and placed along the entire pre-sphincter urethra section and partly in the bladder. Subsequently said tube is fixed in position by means of sutures at the entry of the urethra in the bladder.
After which said drainage tube is coupled to a tubular patch as defined above, which can optionally be constructed during the operation with the winding of a planar patch around the tube and the tubular construction in situ of the patch for urethra in a similar manner to
what takes place in the prior art already described by the Applicant.
Once inserted one inside the other, the tubular patch and the drainage tube are completely in contact one with the other without leaving any free space between them.
In practice the combined use of the present drainage tube with the features defined above with the tubular patch results in an implant for the replacement of one or more removed urethral segments which is improved since it allows not only the complete drainage of the urine from the bladder without side leaks but also the support of the urethral tissue growing on said patch thanks to the properties of radial rigidity provided by the drainage tube.
Moreover said implant is found to be extremely reliable in that the aforesaid drainage tube in coated silicone is extremely resistant to urine and incrustations are not deposited on its surfaces.
Moreover since said drainage tube does not withdraw outwards bacterial migrations and the consequent risk of infections are avoided. "Patch" here is intended to denote soft substrates, in a flat sheet or plate or tubular shape, used in medicine to repair soft tissues, provided with a greater flexibility and elasticity with respect to the scaffolds and to the substrates known as "mesh", "mesh tape" or reinforcement nets. However the present patch is of the type not coated externally since it is implanted in the patient without any coating, in particular without any coating of cultured cells, both internally and externally.
Said patch is preferably constructed in tubular form during the operating session starting from a planar patch, in the form of a polymeric membrane or sheet or in the form of fibres fabric, which is wound externally around the drainage tube, without leaving space between the two, stitched longitudinally and then attached to the ends of the resected section of urethra as will be explained here below. It is also to be understood that a patch can also be used in a single tubular piece, already ready for use, made by means of moulding or extrusion of an appropriate polymeric
material, without thereby departing from the scope of the present invention.
The thickness of the patch can vary from 0.1 microns to 80 microns, preferably around 20-30 microns.
Said patch is made with a biocompatible material which can be resorbable or non- resorbable, preferably PGA so as not to determine any type of alteration in the tissues with which it comes into contact. PGA is a resorbable thermoplastic polymer characterised by a high degree of crystallinity, around 45-55% in the case of the homopolymer. Despite the fact this material degrades thanks to processes of random hydrolysis, and also thanks to some classes of enzymes, such as those belonging to the family of the esterases, it is particularly suitable for not deteriorating in contact with urine for a period of at least two months, not showing any swelling (increase in volume and dimensions) during this period.
PGA also has a time of degradation which ranges from 4-6 months even arriving at 12 months, yet starts to lose its mechanical strength already after 4 weeks and it is completely lost at the fifth month. This is compatible with the cell growth of the tissues of the urethra.
In the case wherein the patch is in PGA, it is preferably in the form of PGA fabric, optionally textured. The PGA fabric is made using an ultra-lightweight multifilament or monofilament yarn deriving from PGA fibres.
The PGA fabric of the patch used in the present invention can be made by weaving in various ways said PGA monofilament or multifilament, creating a knit fabric, a woven fabric or a nonwoven fabric.
It is in any case preferable to use a knit fabric, in particular warp knit, in that provided with a rougher surface with respect to the other types mentioned above. Moreover it is also preferable that the fabric of the patch in PGA is textured. It has in fact been found that texturing, as well as making the fabric rougher on the surface, also
confers a greater impermeability to urine with respect to a non-textured fabric. In fact it can be presumed that the texturing goes to cover further the micro holes which exist between the meshes of the fabric. Texturing of the fabric can be carried out in various ways: through the use of rough surface monofilament obtained according to the methods known in the art, or by heat setting treatment of the fabric to obtain raised parts in the fibres, adding greater volume to the filament. This latter method of texturing is preferred. It is also possible to make the patch (in planar or tubular form) with biocompatible polymers other than PGA, such as for example polylactic acid (PLA), polycaprolactone (PCL) or mixtures thereof.
Other polymers which can be used as patch and normally used in the medical field can be silicone, polysulfone, PE, PP, Dacron (PET), PTFE, PVC, polypropylene and polystyrene, Nylon (66 or 6), Kevlar and more generally synthetic polyamides, Mylar, PE, polyurethanes (Biomer, Pellethane, Corethane and Tecoflex) and polyureas, polyacrylates and others, preferably completely covered by a layer of pyrolytic turbostratic carbon, with a thickness generally around 0.2-0.3 microns, to improve biocompatibility.
An example of these alternative materials to PGA can be a flexible and elastic membrane in soft silicone, which is coated completely with pyrolytic turbostratic carbon with thickness of approximately 0.2-0.3 microns on both sides of the membrane. If the tubular patch is formed during the operation, the starting point is a planar patch which is then wound externally around the tube for drainage inserted between the two free ends of the urethra and stitched longitudinally with suture yarn (resorbable or non- resorbable according to the type of material of the patch) so as to form a tubular patch. In the case wherein the patch is in non-resorbable material it is clear that it must be subsequently removed a certain period of time after grafting.
The tubular patch in a single piece or the membrane of the planar patch from which the non-resorbable tubular device is to be obtained in situ can also incorporate in its thickness a reinforcement net in Dacron which can facilitate the suture of the patch to the urethra avoiding the tearing of said sutures, and/or provide a greater rigidity according to the
need.
Further features of the invention will be made clearer by the following detailed description referred to one of its embodiments which is purely a non-limiting example, illustrated in the accompanying drawings, in which:
Fig. 1 is a perspective and partial view of the pre-sphincter urethra section from which a necrotic segment has been removed, intended to be replaced during the operation by the patch illustrated in a blown-up view;
Figure 2 is a partially sectioned overall view of a human urinary system including bladder and pre-sphincter urethra with the necrotic section removed;
Fig. 3 illustrates the planar patch of Fig. 1 wound around the tube for drainage of Fig. 2 to form during the operation the tubular device in the removed section of urethra.
Figure 2 illustrates the pre-sphincter section of a urethra, denoted by reference numeral 1, affected by necrosis with the necrotic portion removed.
It is to be understood that the following description also applies in the case wherein the urethra has been affected by pathologies other than necrosis such as stenosis, tumours, trauma, iatrogenic lesions and the like, or by congenital malformations.
The surgical removal of the necrotic zone generates two distinct and separate segments of urethra, denoted in Figures 1-2 with the reference numeral 2, 2', which will be placed again in connection one with the other through the insertion, in the missing section, of a non-coated tubular patch in place of the removed zone.
This tubular patch, denoted in Figure 3 by reference numeral 100, is normally made during the operation by the surgeon starting from a planar patch 3, illustrated in Figure 1.
After having performed the resection (removal) of the damaged urethra segment, a drainage tube 10 (Fig. 2) is inserted inside respective lumens 7, 7' (Fig. 2) at the free ends of the two detached segments 2, 2' of urethra.
Said tube for drainage 10 can be straight or slightly curved at the tip if it is necessary to facilitate its passage through the curving of the prostatic urethra.
Moreover said tube 10 can extend just slightly beyond the entrance 4 of the urethra into
the bladder or extend as far as the centre of the bladder (Fig. 2) without thereby departing from the scope of the present invention.
After having inserted the tube for drainage 10 in the lumens 7, 7' of the free ends 2, 2' of the two urethra segments, the tube 10 is sutured along the perimeter of the entrance 4 of the urethra in the bladder 8, using sutures 9 made with yarn for sutures with diameter 1/2 in resorbable material, for example Vycril.
Subsequent to insertion of the tube for drainage 10, the patch in planar form 3 is wound around the portion of drainage tube 10 which is visible, then stitching longitudinally said patch 3 so as to create the tubular patch 100. The longitudinal stitching (not illustrated in the drawing) will be carried out with resorbable or non-resorbable suture yarn according to the type of material used for the patch. In a preferred embodiment said patch 3 and said suture yarn for patch are made in resorbable material.
Once the tubular patch 100 has formed around the tube for drainage 10 its ends are sutured to the free ends of the segments 2, 2' of urethra by means of head-to-head sutures 11 (i.e. the two terminal portions of the lumen of the ureter and of the tubular device are facing one to the other and sutured with continuity).
The tube for drainage 10 will be held in the pre- sphincter urethra section until total regrowth of the urethral new tissue on the patch, generally for a period of approximately 2 months. After which the drainage tube 10 may be removed without surgical intervention, through simple withdrawal thanks to the resorbability of the stitches used.
It should be noted that it is possible to use also an improved method of connection between the segments of urethra and the tubular patch according to what is described in the application MI2012A000646 and in the application USSN 13/481,135 incorporated here in full for reference.
Using the abovementioned procedure, after the removal of the section of urethra affected by a disorder a small longitudinal incision is made on the layer of muscle tissue which forms the external sheath 5 and 5' (Fig. 2) of the two segments 2, 2' of the urethra, leaving instead intact the respective underlying urothelial tissue 6 and 6' : in this way the
detachment is obtained of a portion of external muscle tissue 5 from the underlying portion of urothelial tissue 6.
At this point the ends of the tubular patch 100 will be fitted over the corresponding free ends of the urothelial tubular tissues 6 and 6' and subsequently the flaps of the incision will be brought close together and sutured longitudinally with resorbable yarn so as to restore the external tubular sheath 5 and 5', then suturing as a sandwich the perimeter edge of the tubular patch 100 to both said tissues by means of sutures along the circumference.
In this way it is possible to obtain a homogeneous and uniform regrowth of the muscle tissue 5 and of the urothelial tissue 6 on the surfaces of the tubular patch 100.
It is also possible that the tubular patch 3 is supported with a specific tubular mesh support, of length substantially equal to that of the patch, as described in the patent application MI2013A001716 incorporated here in full for reference, and in this case the drainage tube 10 will be placed inside said tubular support around which said tubular patch 3 is placed. In this case too, once inserted one inside the other, the tubular patch, the tubular support and the drainage tube will be completely in contact one with the other without leaving any free space between the three elements (drainage tube, tubular support, tubular patch).
The polymer of the support is preferably resorbable, for example PGA/PLA (poly(lactic- co-glycolic) acid) the copolymer of lactic acid and glycolic acid where the acronym PLA here is intended to identify the poly(lactic) acid deriving from any type of molecule of lactic acid (chiral molecule): there are in fact different types of polymer indicated by specific acronyms such as PDLA, PLLA, PDLLA, where D and L represent the two stereoisomers of lactic acid, L-lactic acid and D-lactic acid. The PLLA (poly(L- lactic)acid) has a crystallinity of 37%, a glass transition temperature between 50 and 80°C and a melting temperature of 173-178°C, while the polymer deriving from the polymerisation of a racemic mixture of D and L isomers, the PDLLA, is amorphous.
It is to be understood that it is also possible to use a polymeric blend of the two single PLA polymers as defined above and PGA.
Preferably the PLLA is used as PLA.
Generally the copolymer PLLA/PGA (or blend of PGA and PLLA) is formed by 30% of PGA and by 70% of PLLA; preferably as PLLA/PGA a poly(L-lactic-co-glycolic) (PLLA/PGA) copolymer is used in which the L-lactic acid is 82-88% in moles while the glycolic acid is 18-12% in moles.
This specific material makes it possible to obtain a support with mechanical properties of rigidity necessary for supporting the weight of the tubular patch on which the autologous tissue of the urethra is regrowing.
Said support can be obtained by means of moulding, for example injection moulding, and/or thermoforming of the PGA/PLA. Alternatively it is also possible to obtain a very thin tubular support by means of extrusion and subsequently incise the meshes with technologies of cutting for plastics, obtaining directly the geometry required, without the need for mechanical or thermal joints.
The diameter of the support for the tubular patch can be approximately 10 mm in the case of adults and approximately 6 mm in the case of paediatric applications, with a length of 7 mm.
The thickness of the support is generally comprised between 0.056 mm to 1.15 mm or in any case extremely reduced in order to offer the minimal resistance to the urinary flow. Without departing from the scope of the invention a person skilled in the art can bring to the present invention previously described all the changes and the improvements suggested by normal experience and/or by the natural development of the art.
Claims
1. Implant (100) for use in the replacement of at least one urethral segment removed by surgical resection for the treatment of disorders such as necrosis, stenosis, tumours, trauma, iatrogenic lesions and the like, or congenital malformations,
comprising
a tubular patch for connecting two detached segments (2,2') having a respective lumen (7, 7') belonging to a natural urethra of a bladder, said tubular patch being non- coated and made in resorbable or non-resorbable polymeric material, in the form of a polymeric membrane or fibre fabric;
a silicone flexible tube (10) for urine drainage, placed inside said patch, a section of said tube (10) being adapted to be arranged along a pre-sphincter section (1) of said urethra deprived of said removed urethral segment, the remaining section of said tube (10) being placed at the entrance of said bladder;
said implant being characterised in that
said patch is placed externally around said drainage tube (10) in such a way as to be in contact with said drainage tube (10),
said flexible urine drainage tube (10) in silicone is coated, on both the inner and outer surfaces, with a microfilm of pyrolytic turbostratic carbon,
the remaining section of said tube (10) is attached to said bladder by means of resorbable sutures (9) so as to be removable by simple withdrawal without surgical intervention.
2. Implant (100) according to claim 1 wherein said drainage tube (10) has an inner diameter that varies from 12-14 French (Fr) up to a max of 24 Fr, and/or a length that varies from 5 to 20 cm.
3. Implant (100) according to claim 1 or 2 wherein said microfilm of pyrolytic turbostratic carbon has a thickness of about 0.2-0.3 microns.
4. Implant (100) according to any one of the preceding claims wherein the silicone of said drainage tube (10) consists of copolymers of dimethyl- and methavynil-siloxane reinforced with silicon, preferably MED 4735™ of Nusil Technology.
5. Implant (100) according to any one of the preceding claims wherein said resorbable sutures (9) are provided at the entrance of said remaining portion of said drainage tube (10) into the bladder.
6. Implant according to any one of the preceding claims wherein said patch (3) is in resorbable PGA fabric.
7. Implant (100) according to any one of the preceding claims wherein said patch (3) has a thickness that ranges from 0.1 microns to 80 microns.
8. Implant (100) according to any one of the preceding claims wherein said patch (3) is a multifilament or monofilament PGA fabric, optionally textured.
9. Implant according to any one of the preceding claims 1-7 wherein said patch (3) is a membrane sheet of a polymer normally used in the medical field selected from polylactic acid (PLA), polycaprolactone (PCL) or mixtures thereof or selected from silicone, polysulfone, PE, PP, Dacron (PET), PTFE, PVC, polypropylene and polystyrene, Nylon (66 or 6), Kevlar and more generally synthetic polyamides, Mylar, PE, polyurethanes (Biomer, Pellethane, Corethane and Tecoflex) and polyureas, polyacrylates; preferably said membrane being made of silicone coated by a film of pyrolytic turbostratic carbon with a thickness of 0.2-0.3 mm.
10. Implant according to claim 9 wherein said tubular patch (3) incorporates in its thickness a reinforcement net in Dacron.
11. Implant (100) according to claim 7 wherein said patch (3) has a thickness of around 20-30 microns.
12. Implant (100) according to claim 8 wherein the multifilament or monofilament PGA fabric of said patch (3) is textured.
13. Implant according to claim 9 wherein said membrane of said patch (3) is in silicone covered by a film of pyrolytic turbostratic carbon with thickness of 0.2-0.3 mm.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2014A000482 | 2014-03-21 | ||
ITMI20140482 | 2014-03-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015140251A1 true WO2015140251A1 (en) | 2015-09-24 |
Family
ID=50693832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2015/055785 WO2015140251A1 (en) | 2014-03-21 | 2015-03-19 | Drainage tube for urine in silicone with carbon coating for supporting an absorbable device for tissue reconstruction of urethral segment |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015140251A1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2759575A1 (en) * | 1997-02-14 | 1998-08-21 | Assist Publ Hopitaux De Paris | ARTIFICIAL IMPLANT FOR REPLACING THE URINARY EXCRETING APPARATUS IN HUMAN BEINGS |
WO2002004039A2 (en) * | 2000-07-12 | 2002-01-17 | Universitätsklinikum Freiburg | Tube system for reconstructing of hollow organs |
WO2010078949A1 (en) * | 2009-01-07 | 2010-07-15 | Antonio Sambusseti | Orthotopic artificial bladder prosthesis |
WO2011082295A2 (en) * | 2009-12-31 | 2011-07-07 | Neograft Technologies, Inc. | Graft devices and methods of fabrication |
ITMI20120646A1 (en) * | 2012-04-18 | 2013-10-19 | Sambusseti Antonio | PERMANENT TUBULAR DEVICE FOR THE RECONSTRUCTION OF A URETHRAL OR URETERAL SEGMENT MADE OF SILICONE COATED WITH TURBOSTRIC PYROLYTIC CARBON |
ITMI20121555A1 (en) * | 2012-09-19 | 2014-03-20 | Gianni Cancarini | ORTHOTOPIC ENDOPROSTHESIS OF ARTIFICIAL BLADDER |
WO2014057444A1 (en) * | 2012-10-11 | 2014-04-17 | Antonio Sambusseti | Orthotopic artificial bladder endoprosthesis |
-
2015
- 2015-03-19 WO PCT/EP2015/055785 patent/WO2015140251A1/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2759575A1 (en) * | 1997-02-14 | 1998-08-21 | Assist Publ Hopitaux De Paris | ARTIFICIAL IMPLANT FOR REPLACING THE URINARY EXCRETING APPARATUS IN HUMAN BEINGS |
WO2002004039A2 (en) * | 2000-07-12 | 2002-01-17 | Universitätsklinikum Freiburg | Tube system for reconstructing of hollow organs |
WO2010078949A1 (en) * | 2009-01-07 | 2010-07-15 | Antonio Sambusseti | Orthotopic artificial bladder prosthesis |
WO2011082295A2 (en) * | 2009-12-31 | 2011-07-07 | Neograft Technologies, Inc. | Graft devices and methods of fabrication |
ITMI20120646A1 (en) * | 2012-04-18 | 2013-10-19 | Sambusseti Antonio | PERMANENT TUBULAR DEVICE FOR THE RECONSTRUCTION OF A URETHRAL OR URETERAL SEGMENT MADE OF SILICONE COATED WITH TURBOSTRIC PYROLYTIC CARBON |
ITMI20121555A1 (en) * | 2012-09-19 | 2014-03-20 | Gianni Cancarini | ORTHOTOPIC ENDOPROSTHESIS OF ARTIFICIAL BLADDER |
WO2014057444A1 (en) * | 2012-10-11 | 2014-04-17 | Antonio Sambusseti | Orthotopic artificial bladder endoprosthesis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6513187B2 (en) | Composite lumen body having a reinforced woven body and a matrix | |
JP4401165B2 (en) | Composite ePTFE / fiber prosthesis | |
US20080208325A1 (en) | Medical articles for long term implantation | |
US20060058867A1 (en) | Elastomeric radiopaque adhesive composite and prosthesis | |
JP2002540854A (en) | Pipe lining | |
EP2825128B1 (en) | Improved absorbable patch, in reinforced pga, for the replacement of a portion of bladder wall following partial cystectomy | |
US9393099B2 (en) | Orthotopic artificial bladder endoprosthesis | |
US9750597B2 (en) | Orthotopic artificial bladder endoprosthesis | |
US10617513B2 (en) | PGA tubular patch and relative optional tubular support made of absorbable material for the tissue reconstruction of urethral and/or ureteral removed segments | |
WO2015140251A1 (en) | Drainage tube for urine in silicone with carbon coating for supporting an absorbable device for tissue reconstruction of urethral segment | |
JP5919306B2 (en) | A hemisphere for dilating the bladder in hypotensive patients | |
OA17687A (en) | PGA tubular patch and relative optional tubular support made of absorbable material for the tissue reconstruction of urethral and/or ureteral removed segments. | |
US20240148487A1 (en) | Stent with anti-migration features |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15710791 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15710791 Country of ref document: EP Kind code of ref document: A1 |